✦ LIBER ✦

Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: a pilot study

✍ Scribed by T-Y. Chuang; D.A. Lewis; D.F. Spandau

Book ID: 108668299
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 99 KB
Volume: 153
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2005.06738.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Withdrawal of insulin therapy after adju

Withdrawal of insulin therapy after adjunctive treatment with acarbose in a patient with Type 2 diabetes mellitus

✍ Bennett, SMA ;Stewart, MW 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

## Abstract Acarbose has been shown to reduce post‐prandial hyperglycaemia and improve glycaemic control in patients with Type 2 diabetes mellitus. We report its use as an adjunct to established insulin therapy in a 64 year old man with Type 2 diabetes mellitus and secondary failure to treatment wi

Insulin, glucose and the increased risk

Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes

✍ J. A. Johnson; M. Pollak 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 84 KB

Insulin Therapy and Colorectal Adenoma R

Insulin Therapy and Colorectal Adenoma Risk Among Patients with Type 2 Diabetes Mellitus: A Case-Control Study in Korea

✍ Yong Woo Chung; Dong Soo Han; Kwang Hyuk Park; Chang Soo Eun; Kyo-Sang Yoo; Choo 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 120 KB

Effect of insulin on blood rheology in n

Effect of insulin on blood rheology in non-diabetic subjects and in patients with type 2 diabetes mellitus

✍ Coppola, L.; Verrazzo, G.; La Marca, C.; Ziccardi, P.; Grassia, A.; Tirelli, A.; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

We evaluated the effect of insulin on platelet function, blood viscosity, and filterability in healthy subjects and in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Fifteen diabetic patients were free from cardiovascular complications (group A), while the other 15 patients had both

Clinical characteristics of patients wit

Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain

✍ María Costi; Tatiana Dilla; Jesús Reviriego; Conxa Castell; Albert Goday 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 261 KB

Pravastatin compared to bezafibrate in t

Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus

✍ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background Both HMG-CoA reductase inhibitors and ®bric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg beza®brate, a ®bric acid deriva